






Wolverine Blend, widely known as the Wolverine stack, puts BPC-157 and TB-500 in one vial for laboratory research. They are the most commonly paired peptides in research catalogs, and two of the most studied. BPC-157 is a 15-amino-acid partial sequence of a protein found in gastric juice, studied for growth factor receptor signaling and for the FAK-paxillin pathway that anchors cells to their surroundings. TB-500 carries the 43-amino-acid sequence of thymosin beta-4, which binds actin inside the cell and governs how readily a cell can change shape and move. The two reach related cell behaviors, migration, attachment and blood vessel formation, by different routes, which is why researchers so often study them side by side. Each vial is labeled 10 mg of each peptide, so the ratio is fixed at manufacture and stays constant from experiment to experiment within a lot, with no separate compounds to prepare and combine. Lot reports come from an independent third-party laboratory and confirm the identity of both peptides by HPLC, alongside purity, net peptide content, heavy metals, sterility and endotoxin. How the two mechanisms interact is still an open research question. Run alongside the single BPC-157 and TB-500 vials as controls, the blend gives a lab all three arms that question needs.
Structured specifications and handling data
Technical specifications
BPC-157 (15aa) + TB-500 (43aa)Stability and handling
Molecular model
Loading 3D Molecule...
Compounds commonly studied alongside this one.
Related research:
BPC-157 and TB-500 work through different mechanisms. BPC-157 is a gastric peptide fragment that interacts with growth factor receptors, nitric oxide pathways, and the signaling systems involved in forming new blood vessels. TB-500 is a synthetic copy of thymosin beta-4 that binds actin, the structural protein that controls cell shape and movement. By combining them, researchers can study what happens when these two distinct signaling profiles are present together.
In laboratory settings, BPC-157 has been associated with VEGF expression (a key blood vessel growth signal) and with how cells grip and attach to surfaces. TB-500 has been linked to cytoskeletal reorganization, which is the process by which a cell rearranges its internal scaffolding to move or change shape. The idea behind studying them together is that they may influence overlapping but different steps in the same cellular processes.
Direct combination research is still early. A 2026 rat tendon study compared each peptide alone with the two together, measuring tendon strength, tissue structure and collagen, which is the three-arm design the blend and the single peptides make possible. This blend gives researchers a practical way to explore multi-peptide signaling interactions without needing to prepare and combine separate compounds.
Published studies and concise summaries for research review.
AI-generated summary of this research paper below.
Concise answers about laboratory context, handling, and documentation for this compound.
Laboratory compliance notice
All compounds sold by Validated Peptides are intended for in-vitro laboratory research only.
These materials are not approved by the FDA for human or animal use and are not intended for diagnostic, therapeutic, or clinical applications.
Purchasers are responsible for compliant handling, storage, and use within an appropriate laboratory environment.